A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from USC suggests that semaglutide—the drug marketed as Ozempic for diabetes and Wegovy for obesity—may also help reduce alcohol consumption.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.